The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169 · cited 1×
“important factor influencing plasma efavirenz concentrations [142, 143], a significant association of the 30-noncoding ABCB1 SNP c.”
Self-citationBIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
Gottesman, M. M., & Pastan, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002125 · Cited by 3,568
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity
Kimchi-Sarfaty, C., Oh, J. M., Kim, I.-W., Sauna, Z. E., Calcagno, A. M., Ambudkar, S. V., & Gottesman, M. M. (2007) · Science · doi:10.1126/science.1135308 · Cited by 2,416
Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H. P., Brockmöller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3473 · Cited by 2,365
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Oudard, S., Negrier, S., Szczylik, C., Pili, R., Bjarnason, G. A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.1293 · Cited by 2,181
BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I., & Gottesman, M. M. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.361 · Cited by 2,059
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Aller, S. G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P. M., Trinh, Y. T., Zhang, Q., Urbatsch, I. L., et al. (2009) · Science · doi:10.1126/science.1168750 · Cited by 1,929
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
Pharmacogenomics Knowledge for Personalized Medicine
Whirl-Carrillo, M., McDonagh, E. M., Hebert, J. M., Gong, L., Sangkuhl, K., Thorn, C. F., Altman, R. B., & Klein, T. E. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.96 · Cited by 1,796
Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
Simon, T., Verstuyft, C., Mary-Krause, M., Quteineh, L., Drouet, E., Méneveau, N., Steg, P. G., Ferrières, J., Danchin, N., & Becquemont, L. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808227 · Cited by 1,728
Expression of a multidrug-resistance gene in human tumors and tissues.
Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., & Pastan, I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.265 · Cited by 1,544
Schinkel, A. H., Wagenaar, E., Mol, C. A., & van Deemter, L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118699 · Cited by 1,264
Bonello, L., Tantry, U. S., Marcucci, R., Blindt, R., Angiolillo, D. J., Becker, R., Bhatt, D. L., Cattaneo, M., Collet, J. P., Cuisset, T., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.04.047 · Cited by 1,149
Kim, R. B., Fromm, M. F., Wandel, C., Leake, B., Wood, A. J., Roden, D. M., & Wilkinson, G. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1269 · Cited by 1,054
Identification of functionally variant MDR1 alleles among European Americans and African Americans
Kim, R. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.117412 · Cited by 1,009
Blood-brain barrier active efflux transporters: ATP-binding cassette gene family
Löscher, W., & Potschka, H. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.86 · Cited by 872
Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin
Geick, A., Eichelbaum, M., & Burk, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010173200 · Cited by 848
Marzolini, C., Telenti, A., Decosterd, L. A., Greub, G., Biollaz, J., & Buclin, T. (2001) · AIDS · doi:10.1097/00002030-200101050-00011 · Cited by 840
Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines
Riordan, J. R., Deuchars, K., Kartner, N., Alon, N., Trent, J., & Ling, V. (1985) · Nature · doi:10.1038/316817a0 · Cited by 826
Wallentin, L., James, S., Storey, R. F., Armstrong, M., Barratt, B. J., Horrow, J., Husted, S., Katus, H., Steg, P. G., Shah, S. H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61274-3 · Cited by 799
Cascorbi, I. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.114164 · Cited by 747
Is the multidrug transporter a flippase?
Higgins, C. F., & Gottesman, M. M. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90419-a · Cited by 722
Human P-glycoprotein transports cyclosporin A and FK506.
Saeki, T., Ueda, K., Tanigawara, Y., Hori, R., & Komano, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53221-x · Cited by 684
Siddiqui, A., Kerb, R., Weale, M. E., Brinkmann, U., Smith, A., Goldstein, D. B., Wood, N. W., & Sisodiya, S. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021986 · Cited by 665
Fellay, J., Marzolini, C., Meaden, E. R., Back, D. J., Buclin, T., Chave, J.-P., Decosterd, L. A., Furrer, H., Opravil, M., Pantaleo, G., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07276-8 · Cited by 658
Hesselink, D. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00168-1 · Cited by 655
von Beckerath, N., Taubert, D., Pogatsa-Murray, G., Schömig, E., Kastrati, A., & Schömig, A. (2005) · Circulation · doi:10.1161/circulationaha.105.559088 · Cited by 623
Mega, J. L., Close, S. L., Wiviott, S. D., Shen, L., Walker, J. R., Simon, T., Antman, E. M., Braunwald, E., & Sabatine, M. S. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61273-1 · Cited by 614
Importance of P-glycoprotein at blood–tissue barriers
Fromm, M. F. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.06.002 · Cited by 592 · cited 1×
“Moreover, hepatic ABCB1 protein levels show large inter-individual variability of up to 50-fold [68–71], which could contribute to differences in drug Table 1 ATP-binding cassette transporter B1 (ABCB1) substrates and modulators [7, 35, 223] Group Drugs”
JOHNE, A. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1053/cp.1999.v66.a101944 · Cited by 586
The molecular basis of multidrug resistance in cancer: The early years of P‐glycoprotein research
Gottesman, M. M., & Ling, V. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.12.060 · Cited by 558
MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models
Mahon, F.-X., Belloc, F., Lagarde, V., Chollet, C., Moreau-Gaudry, F., Reiffers, J., Goldman, J. M., & Melo, J. V. (2003) · Blood · doi:10.1182/blood.v101.6.2368 · Cited by 538
Tanabe, M., Ieiri, I., Nagata, N., Inoue, K., Ito, S., Kanamori, Y., Takahashi, M., Kurata, Y., Kigawa, J., Higuchi, S., et al. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29643-9 · Cited by 533
Sex Is A Major Determinant of Cyp3a4 Expression in Human Liver
Wolbold, R., Klein, K., Burk, O., Nüssler, A. K., Neuhaus, P., Eichelbaum, M., Schwab, M., & Zanger, U. M. (2003) · Hepatology · doi:10.1002/hep.1840380424 · Cited by 529
Self-citationMDR1 Gene Expression in Brain of Patients with Medically Intractable Epilepsy
Tishler, D. M., Weinberg, K. I., Hinton, D. R., Barbaro, N., Annett, G. M., & Raffel, C. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb01657.x · Cited by 527
Lara, P. N., Natale, R., Crowley, J., Lenz, H. J., Redman, M. W., Carleton, J. E., Jett, J., Langer, C. J., Kuebler, J. P., Dakhil, S. R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.1061 · Cited by 525
Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability
Wang, D., Johnson, A. D., Papp, A. C., Kroetz, D. L., & Sadée, W. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000178311.02878.83 · Cited by 490
Impact of P-glycoprotein on clopidogrel absorption
Taubert, D., VONBECKERATH, N., Grimberg, G., Lazar, A., JUNG, N., Goeser, T., Kastrati, A., Schömig, A., & Schömig, E. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.07.007 · Cited by 453
Haufroid, V., Mourad, M., Van Kerckhove, V., Wawrzyniak, J., De Meyer, M., Eddour, D. C., Malaise, J., Lison, D., Squifflet, J.-P., & Wallemacq, P. (2004) · Pharmacogenetics · doi:10.1097/00008571-200403000-00002 · Cited by 447
Very important pharmacogene summary
Hodges, L. M., Markova, S. M., Chinn, L. W., Gow, J. M., Kroetz, D. L., Klein, T. E., & Altman, R. B. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283385a1c · Cited by 436
Kroetz, D. L., Pauli-Magnus, C., Hodges, L. M., Huang, C. C., Kawamoto, M., Johns, S. J., Stryke, D., Ferrin, T. E., DeYoung, J., Taylor, T., et al. (2003) · Pharmacogenetics · doi:10.1097/00008571-200308000-00006 · Cited by 429
Role of Multidrug Transporters in Pharmacoresistance to Antiepileptic Drugs
Löscher, W., & Potschka, H. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.1.7 · Cited by 409
Ameyaw, M.-M., Regateiro, F., Li, T., Liu, X., Tariq, M., Mobarek, A., Thornton, N., Folayan, G. O., Githang'a, J., Indalo, A., et al. (2001) · Pharmacogenetics · doi:10.1097/00008571-200104000-00005 · Cited by 409
Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells.
Raviv, Y., Pollard, H. B., Bruggemann, E. P., Pastan, I., & Gottesman, M. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39690-5 · Cited by 387
Uhr, M., Tontsch, A., Namendorf, C., Ripke, S., Lucae, S., Ising, M., Dose, T., Ebinger, M., Rosenhagen, M., Kohli, M., et al. (2008) · Neuron · doi:10.1016/j.neuron.2007.11.017 · Cited by 382
Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs
Cascorbi, I. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.04.009 · Cited by 355
Functional involvement of P-glycoprotein in blood-brain barrier.
Tatsuta, T., Naito, M., Oh-hara, T., Sugawara, I., & Tsuruo, T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88713-6 · Cited by 347
Staatz, C. E., Goodman, L. K., & Tett, S. E. (2010) · Clinical Pharmacokinetics · doi:10.2165/11317550-000000000-00000 · Cited by 343
Tanigawara, Y., Okamura, N., Hirai, M., Yasuhara, M., Ueda, K., Kioka, N., Komano, T., & Hori, R. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10423-0 · Cited by 337
Staatz, C. E., Goodman, L. K., & Tett, S. E. (2010) · Clinical Pharmacokinetics · doi:10.2165/11317350-000000000-00000 · Cited by 336
A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function
Fung, K. L., & Gottesman, M. M. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.02.014 · Cited by 335
Sakaeda, T., Nakamura, T., Horinouchi, M., Kakumoto, M., Ohmoto, N., Sakai, T., Morita, Y., Tamura, T., Aoyama, N., Hirai, M., et al. (2001) · Pharmaceutical Research · doi:10.1023/a:1012244520615 · Cited by 322
Macphee, I. A. M., Fredericks, S., Tai, T., Syrris, P., Carter, N. D., Johnston, A., Goldberg, L., & Holt, D. W. (2002) · Transplantation · doi:10.1097/00007890-200212150-00002 · Cited by 315
Genetic Polymorphisms of the Human MDR1 Drug Transporter
Schwab, M., Eichelbaum, M., & Fromm, M. F. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140233 · Cited by 308
Self-citationModulation of steady‐state kinetics of digoxin by haplotypes of the P‐glycoprotein MDR1 gene
Johne, A., Köpke, K., Gerloff, T., Mai, I., Rietbrock, S., Meisel, C., Hoffmeyer, S., Kerb, R., Fromm, M. F., Brinkmann, U., et al. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.129196 · Cited by 306
Leschziner, G. D., Andrew, T., Pirmohamed, M., & Johnson, M. R. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500413 · Cited by 300
Mayer, U., Wagenaar, E., Beijnen, J. H., Smit, J. W., Meijer, D. K. F., van Asperen, J., Borst, P., & Schinkel, A. H. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15775.x · Cited by 282
Frequency of C3435T polymorphism of MDR1 gene in African people
Schaeffeler, E., Eichelbaum, M. F., Brinkmann, U., Penger, A., Asante-Poku, S., Zanger, U. M., & Schwab, M. G. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05579-9 · Cited by 281
Self-citationAnglicheau, D., Verstuyft, C. A. A., Laurent-Puig, P., Becquemont, L., Schlageter, M.-H. A. A. G. A., Cassinat, B., Beaune, P., Legendre, C., & Thervet, E. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000073901.94759.36 · Cited by 281
Kurata, Y., Ieiri, I., Kimura, M., Morita, T., Irie, S., Urae, A., Ohdo, S., Ohtani, H., Sawada, Y., Higuchi, S., et al. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.126177 · Cited by 269
Schuetz, E. G., Furuya, K. N., & Schuetz, J. D. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12089-2 · Cited by 265
Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition
Ramsey, L. B., Bruun, G. H., Yang, W., Treviño, L. R., Vattathil, S., Scheet, P., Cheng, C., Rosner, G. L., Giacomini, K. M., Fan, Y., et al. (2012) · Genome Research · doi:10.1101/gr.129668.111 · Cited by 261
Nakamura, T., Sakaeda, T., Horinouchi, M., Tamura, T., Aoyama, N., Shirakawa, T., Matsuo, M., Kasuga, M., & Okumura, K. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.122055 · Cited by 260
MacPhee, I. A. M., Fredericks, S., Tai, T., Syrris, P., Carter, N. D., Johnston, A., Goldberg, L., & Holt, D. W. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00435.x · Cited by 258
von Richter, O., Burk, O., Fromm, M. F., Thon, K. P., Eichelbaum, M., & Kivistö, K. T. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.10.008 · Cited by 255
Tsuchiya, N., Satoh, S., Tada, H., Li, Z., Ohyama, C., Sato, K., Suzuki, T., Habuchi, T., & Kato, T. (2004) · Transplantation · doi:10.1097/01.tp.0000137789.58694.b4 · Cited by 250
Human P-Glycoprotein Exhibits Reduced Affinity for Substrates during a Catalytic Transition State
Ramachandra, M., Ambudkar, S. V., Chen, D., Hrycyna, C. A., Dey, S., Gottesman, M. M., & Pastan, I. (1998) · Biochemistry · doi:10.1021/bi973045u · Cited by 249
Marsh, S., Paul, J., King, C. R., Gifford, G., McLeod, H. L., & Brown, R. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.4752 · Cited by 238
Uhr, M., Grauer, M. T., & Holsboer, F. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00074-x · Cited by 237
Dulucq, S., Bouchet, S., Turcq, B., Lippert, E., Etienne, G., Reiffers, J., Molimard, M., Krajinovic, M., & Mahon, F.-X. (2008) · Blood · doi:10.1182/blood-2008-03-147744 · Cited by 236
Garcia-Donas, J., Esteban, E., Leandro-García, L. J., Castellano, D. E., del Alba, A. G., Climent, M. A., Arranz, J. A., Gallardo, E., Puente, J., Bellmunt, J., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70266-2 · Cited by 225
Baltes, S., Gastens, A. M., Fedrowitz, M., Potschka, H., Kaever, V., & Löscher, W. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.07.038 · Cited by 223
Meier, Y., Pauli-Magnus, C., Zanger, U. M., Klein, K., Schaeffeler, E., Nussler, A. K., Nussler, N., Eichelbaum, M., Meier, P. J., & Stieger, B. (2006) · Hepatology · doi:10.1002/hep.21214 · Cited by 219
Self-citationN-glycosylation and deletion mutants of the human MDR1 P-glycoprotein.
Schinkel, A. H., Kemp, S., Dollé, M., Rudenko, G., & Wagenaar, E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53199-9 · Cited by 214
Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy
Tan, N. C. K., Heron, S. E., Scheffer, I. E., Pelekanos, J. T., McMahon, J. M., Vears, D. F., Mulley, J. C., & Berkovic, S. F. (2004) · Neurology · doi:10.1212/01.wnl.0000137051.33486.c7 · Cited by 211
Kuypers, D. R. J., de Jonge, H., Naesens, M., Lerut, E., Verbeke, K., & Vanrenterghem, Y. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100216 · Cited by 209
Burger, D., Van Der Heiden, I., La Porte, C., Van Der Ende, M., Groeneveld, P., Richter, C., Koopmans, P., Kroon, F., Sprenger, H., Lindemans, J., et al. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02536.x · Cited by 209
P-glycoprotein: Tissue Distribution, Substrates, and Functional Consequences of Genetic Variations
Cascorbi, I. (2011) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-14541-4_6 · Cited by 204
Siegmund, W., Ludwig, K., Giessmann, T., Dazert, P., Schroeder, E., Sperker, B., Warzok, R., Kroemer, H. K., & Cascorbi, I. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.127739 · Cited by 199
Prasad, B., Evers, R., Gupta, A., Hop, C. E. C. A., Salphati, L., Shukla, S., Ambudkar, S. V., & Unadkat, J. D. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.053819 · Cited by 195
Han, J., Lim, H., Yoo, Y., Shin, E. S., Park, Y. H., Lee, S. Y., Lee, J., Lee, D. H., Kim, H. T., & Lee, J. S. (2007) · Cancer · doi:10.1002/cncr.22760 · Cited by 195
Goto, M., Masuda, S., Saito, H., Uemoto, S., Kiuchi, T., Tanaka, K., & Inui, K.-I. (2002) · Pharmacogenetics · doi:10.1097/00008571-200208000-00005 · Cited by 193
CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation
Anglicheau, D. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.01.009 · Cited by 193
Goto, M., Masuda, S., Kiuchi, T., Ogura, Y., Oike, F., Okuda, M., Tanaka, K., & Inui, K.-I. (2004) · Pharmacogenetics · doi:10.1097/01.fpc.0000114747.08559.49 · Cited by 189
Yamauchi, A., Ieiri, I., Kataoka, Y., Tanabe, M., Nishizaki, T., Oishi, R., Higuchi, S., Otsubo, K., & Sugimachi, K. (2002) · Transplantation · doi:10.1097/00007890-200208270-00024 · Cited by 184
Pharmacogenetic Pathway Analysis for Determination of Sunitinib-Induced Toxicity
van Erp, N. P., Eechoute, K., van der Veldt, A. A., Haanen, J. B., Reyners, A. K. L., Mathijssen, R. H. J., Boven, E., van der Straaten, T., Baak-Pablo, R. F., Wessels, J. A. M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.7679 · Cited by 183
Haufroid, V., Wallemacq, P., VanKerckhove, V., Elens, L., De Meyer, M., Eddour, D. C., Malaise, J., Lison, D., & Mourad, M. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01518.x · Cited by 181
Clinical Aspects of the MDR1 (ABCB1) Gene Polymorphism
Eichelbaum, M., Fromm, M. F., & Schwab, M. (2004) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200404000-00017 · Cited by 176
Self-citationKato, M., Fukuda, T., Serretti, A., Wakeno, M., Okugawa, G., Ikenaga, Y., Hosoi, Y., Takekita, Y., Mandelli, L., Azuma, J., et al. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.09.003 · Cited by 174
Gréen, H., Söderkvist, P., Rosenberg, P., Horváth, G., & Peterson, C. O. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0950 · Cited by 173
Germann, U. A., Chambers, T. C., Ambudkar, S. V., Licht, T., Cardarelli, C. O., Pastan, I., & Gottesman, M. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1708 · Cited by 172
Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia
Sissung, T. M., Mross, K., Steinberg, S. M., Behringer, D., Figg, W. D., Sparreboom, A., & Mielke, S. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.06.017 · Cited by 170
Bruhn, O., & Cascorbi, I. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.952630 · Cited by 168
Ieiri, I. (2012) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-11-rv-098 · Cited by 164
Linnet, K., & Ejsing, T. B. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.06.003 · Cited by 163
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Warden, D., McKinney, W., Downing, M., Berman, S. R., Farabaugh, A., Luther, J. F., Nierenberg, A. A., et al. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0203 · Cited by 160
ABCB1 Polymorphisms Influence the Response to Antiepileptic Drugs in Japanese Epilepsy Patients
Seo, T., Ishitsu, T., Ueda, N., Nakada, N., Yurube, K., Ueda, K., & Nakagawa, K. (2006) · Pharmacogenomics · doi:10.2217/14622416.7.4.551 · Cited by 159
Baltes, S., Fedrowitz, M., Tortós, C. L., Potschka, H., & Löscher, W. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.102491 · Cited by 159
Meyer, U. A., Zanger, U. M., & Schwab, M. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100502 · Cited by 157
Self-citationMDR1 Genotype-related Pharmacokinetics: Fact or Fiction?
Sakaeda, T. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.391 · Cited by 150
Zheng, H., Zeevi, A., Schuetz, E. G., Lamba, J. K., McCurry, K. R., Griffith, B. P., Webber, S., Ristich, J., Dauber, J. H., Iacono, A. T., et al. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003262108 · Cited by 149
Haas, D. W., Bartlett, J. A., Andersen, J. W., Sanne, I., Wilkinson, G. R., Hinkle, J. E., Rousseau, F. S., Ingram, C. D., Shaw, A. L., Lederman, M. M., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/507097 · Cited by 145
Imatinib Disposition and ABCB1 (MDR1, P-Glycoprotein) Genotype
Gurney, H., Wong, M., Balleine, R. L., Rivory, L. P., McLachlan, A. J., Hoskins, J. M., Wilcken, N., Clarke, C. L., Mann, G. J., Collins, M., et al. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100201 · Cited by 143
Sai, K., Kaniwa, N., Itoda, M., Saito, Y., Hasegawa, R., Komamura, K., Ueno, K., Kamakura, S., Kitakaze, M., Shirao, K., et al. (2003) · Pharmacogenetics · doi:10.1097/00008571-200312000-00005 · Cited by 143
Renders, L., Mv, F., Ufer, M., Mosyagin, I., Haenisch, S., Ott, U., Caliebe, A., Dechant, M., Braun, F., Kunzendorf, U., et al. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100039 · Cited by 142
Hesselink, D. A., van Schaik, R. H. N., van Agteren, M., de Fijter, J. W., Hartmann, A., Zeier, M. G., Budde, K., Kuypers, D. R. J., Pisarski, P., Meur, Y. L., et al. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f75f88 · Cited by 140
Sissung, T. M., Baum, C. E., Deeken, J. F., Price, D. K., Aragon‐Ching, J. B., Steinberg, S. M., Dahut, W. L., Sparreboom, A., & Figg, W. D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4230 · Cited by 140
Hitzl, M., Schaeffeler, E., Hocher, B., Slowinski, T., Halle, H., Eichelbaum, M. F., Kaufmann, P., Fritz, P., Fromm, M. F., & Schwab, M. G. (2004) · Pharmacogenetics · doi:10.1097/00008571-200405000-00006 · Cited by 137
Self-citationLal, S., Wong, Z. W., Sandanaraj, E., Xiang, X., Ang, P., Lee, E. J. D., & Chowbay, B. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00744.x · Cited by 137
Schaich, M. A., Kestel, L., Pfirrmann, M., Robel, K., Illmer, T., Krämer, M., Dill, C., Ehninger, G., Schackert, G., & Krex, D. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn548 · Cited by 133
Horinouchi, M., Sakaeda, T., Nakamura, T., Morita, Y., Tamura, T., Aoyama, N., Kasuga, M., & Okumura, K. (2002) · Pharmaceutical Research · doi:10.1023/a:1020433422259 · Cited by 128
Uhr, M., & Grauer, M. T. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00022-0 · Cited by 126
Chowbay, B., Li, H., Machin, D., Cheung, Y. B., & Lee, E. J. D. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02392.x · Cited by 119
Kuypers, D. R. J., Naesens, M., de Jonge, H., Lerut, E., Verbeke, K., & Vanrenterghem, Y. F. C. (2010) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3181e06818 · Cited by 119
Fung, K. L., Pan, J., Ohnuma, S., Lund, P. E., Pixley, J. N., Kimchi‐Sarfaty, C., Ambudkar, S. V., & Gottesman, M. M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2064 · Cited by 118
Gribar, J. J., Ramachandra, M., Hrycyna, C. A., Dey, S., & Ambudkar, S. V. (2000) · The Journal of Membrane Biology · doi:10.1007/s002320001020 · Cited by 116
Ni, L., Li, J., Miao, K., Qiao, C., Zhang, S., Qiu, H., & Qian, S. (2010) · Medical Oncology · doi:10.1007/s12032-010-9456-9 · Cited by 116
Complex Haplotypic Effects of the ABCB1 Gene on Epilepsy Treatment Response
Hung, C., Tai, J. J., Lin, C., Lee, M., & Liou, H. (2005) · Pharmacogenomics · doi:10.1517/14622416.6.4.411 · Cited by 116
García‐Bournissen, F., Moretti, M. E., Juurlink, D. N., Koren, G., Walker, M. J. K., & Finkelstein, Y. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.01858.x · Cited by 112
Quantification and Characterization of P-Glycoprotein−Substrate Interactions
Gatlik-Landwojtowicz, E., Äänismaa, P., & Seelig, A. (2006) · Biochemistry · doi:10.1021/bi051380+ · Cited by 111
Tada, H., Tsuchiya, N., Satoh, S., Kagaya, H., Li, Z., Sato, K., Miura, M., Suzuki, T., Kato, T., & Habuchi, T. (2005) · Transplantation Proceedings · doi:10.1016/j.transproceed.2005.02.073 · Cited by 110
CYP3A4*22 Genotype and Systemic Exposure Affect Paclitaxel-Induced Neurotoxicity
de Graan, A. M., Elens, L., Sprowl, J. A., Sparreboom, A., Friberg, L. E., van der Holt, B., de Raaf, P. J., de Bruijn, P., Engels, F. K., Eskens, F. A. L. M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3786 · Cited by 108
ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression
Sarginson, J. E., Lazzeroni, L. C., Ryan, H. S., Ershoff, B. D., Schatzberg, A. F., & Murphy, G. M. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833b593a · Cited by 105
Stöhr, W., Back, D. J., Dunn, D. T., Sabin, C. A., Winston, A., Gilson, R. J. C., Pillay, D., Hill, T., Ainsworth, J., Pozniak, A., et al. (2008) · Antiviral Therapy · doi:10.1177/135965350801300507 · Cited by 104
Chang, H., Rha, S. Y., Jeung, H., Im, C. K., Ahn, J. B., Kwon, W. S., Yoo, N. C., Roh, J. K., & Chung, H. C. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn624 · Cited by 104
Elens, L., Capron, A., Kerckhove, V. V., Lerut, J. P., Mourad, M., Lison, D., Wallemacq, P. E., & Haufroid, V. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282e9a533 · Cited by 100
den Buijsch, R. A. M. O., Christiaans, M. H. L., Stolk, L. M., de Vries, J. E., Cheung, C. Y., Undre, N. A., van Hooff, J. P., van Dieijen‐Visser, M. P., & Bekers, O. (2007) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2007.00504.x · Cited by 100
Xiang, Q., Zhao, X., Zhou, Y. F., Duan, J. L., & Cui, Y. M. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009347867 · Cited by 99
Beuselinck, B., Karadimou, A., Lambrechts, D., Claes, B., Wolter, P., Couchy, G., Berkers, J., Paridaens, R., Schöffski, P., Méjean, A., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.548 · Cited by 98
Yong-fang, H., Qiu, W., Liu, Z., Zhu, L., Liu, Z., Tu, J., Wang, D., Li, Z., He, J., Zhong, G., et al. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04492.x · Cited by 98
MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression
Peleš, A. M., Božina, N., Šagud, M., Kuzman, M. R., & Lovrić, M. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.03.018 · Cited by 96
Mizuno, T., Fukudo, M., Terada, T., Kamba, T., Nakamura, E., Ogawa, O., Inui, K., & Katsura, T. (2012) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-12-rg-026 · Cited by 95
Genomic evidence for recent positive selection at the human MDR1 gene locus
Tang, K., Wong, L.-P., Lee, E. J. D., Chong, S. S., & Lee, C. G. L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh099 · Cited by 95
Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer
Zhou, Q. S., Sparreboom, A., Tan, E.-H., Cheung, Y., Lee, A., Poon, D. Y. H., Lee, E. J. D., & Chowbay, B. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02330.x · Cited by 94
Xing, Q., Gao, R., Li, H., Feng, G., Xu, M., Duan, S., Meng, J., Zhang, A., Qin, S., & He, L. (2006) · Pharmacogenomics · doi:10.2217/14622416.7.7.987 · Cited by 94
Jovanović, N., Božina, N., Lovrić, M., Medved, V., Jakovljević, M., & Peleš, A. M. (2010) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0850-1 · Cited by 93
Cerebral expression of drug transporters in epilepsy
Aronica, E., Sisodiya, S. M., & Gorter, J. A. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.008 · Cited by 93
Fukudo, M., Ikemi, Y., Togashi, Y., Masago, K., Kim, Y. H., Mio, T., Terada, T., Teramukai, S., Mishima, M., Inui, K., et al. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0058-5 · Cited by 90
Qiu, X., Jiao, Z., Zhang, M., Zhong, L.-J., Hui-qi, L., Ma, C.-L., Zhang, L., & Zhong, M. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0520-8 · Cited by 89
Božina, N., Kuzman, M. R., Medved, V., Jovanović, N., Sertić, J., & Hotujac, L. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.10.002 · Cited by 87
CYP2C8*3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxel
Hertz, D. L., Motsinger‐Reif, A. A., Drobish, A. A., Winham, S. J., McLeod, H. L., Carey, L., & Dees, E. C. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2054-0 · Cited by 87
Lin, K., Chiu, Y., Tsai, I., Chen, C., Shen, W. W., Liu, S. C., Lu, S., Liu, C.-Y., Hsiao, M., Tang, H., et al. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833db216 · Cited by 86
Owen, A., Goldring, C. E., Morgan, P., Chadwick, D. W., Park, B. K., & Pirmohamed, M. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02229.x · Cited by 85
Meissner, K., Jedlitschky, G., zu Schwabedissen, H. E. M., Dazert, P., Eckel, L., Vogelgesang, S., Warzok, R., B�hm, M., Lehmann, C., Wendt, M., et al. (2004) · Pharmacogenetics · doi:10.1097/00008571-200406000-00007 · Cited by 83
Su, J., Xu, J., Li, X., Zhang, H., Hu, J., Fang, R., & Chen, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046366 · Cited by 82
Haerian, B. S., Roslan, H., Raymond, A. A., Tan, C. T., Lim, K. S., Zulkifli, S. Z., Mohamed, E. H. M., Tan, H. J., & Mohamed, Z. (2010) · Seizure · doi:10.1016/j.seizure.2010.05.004 · Cited by 82
Leschziner, G., Jorgensen, A., Andrew, T., Pirmohamed, M., Williamson, P., Marson, A., Coffey, A., Middleditch, C., Rogers, J., Bentley, D., et al. (2006) · Lancet Neurology · doi:10.1016/s1474-4422(06)70500-2 · Cited by 78
ABCB1 polymorphisms are Associated with Clozapine Plasma Levels in Psychotic Patients
Consoli, G., Lastella, M., Ciapparelli, A., Dell’Osso, M. C., Ciofi, L., Guidotti, E., Danesi, R., Dell’Osso, L., Tacca, M. D., & Paolo, A. D. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.51 · Cited by 77
Ciccacci, C., Borgiani, P., Ceffa, S., Sirianni, E., Marazzi, M. C., Altan, A. M. D., Paturzo, G., Bramanti, P., Novelli, G., & Palombi, L. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.142 · Cited by 76
Provenzani, A., Notarbartolo, M., Labbozzetta, M., Poma, P., Vizzini, G., Salis, P., Caccamo, C., Bertani, T., Palazzo, U., Polidori, P., et al. (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.794 · Cited by 75
Pharmacogenetics of ATP-Binding Cassette Transporters and Clinical Implications
Cascorbi, I., & Haenisch, S. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-416-6_6 · Cited by 75
Thuerauf, N., & Fromm, M. F. (2006) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-006-0662-6 · Cited by 74
Shi, Y., Li, Y., Tang, J., Zhang, J., Zou, Y., Cai, B., & Wang, L. (2012) · Gene · doi:10.1016/j.gene.2012.10.048 · Cited by 74
Kim, H., Im, S., Keam, B., Ham, H. S., Lee, K. H., Kim, T. Y., Kim, Y. J., Oh, D., Kim, J. H., Han, W., et al. (2014) · Cancer Science · doi:10.1111/cas.12560 · Cited by 73
Colombo, S. F., Soranzo, N., Rotger, M., Sprenger, R., Bleiber, G., Furrer, H., Buclin, T., Goldstein, D. B., Decosterd, L. A., & Telenti, A. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000172241.42546.d3 · Cited by 72
Leschziner, G. D., Zabaneh, D., Pirmohamed, M., Owen, A., Rogers, J., Coffey, A. J., Balding, D. J., Bentley, D., & Johnson, M. R. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000197467.21964.67 · Cited by 71
Donor ABCB1 Variant Associates with Increased Risk for Kidney Allograft Failure
Moore, J., McKnight, A. J., Döhler, B., Simmonds, M. J., Courtney, A. E., Brand, O. J., Briggs, D., Ball, S. T., Cockwell, P., Patterson, C., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012030260 · Cited by 71
Ghotbi, R., Mannheimer, B., Aklillu, E., Suda, A., Bertilsson, L., Eliasson, E., & Ösby, U. (2010) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0783-8 · Cited by 69
Yasui‐Furukori, N., Mihara, K., Takahata, T., Suzuki, A., Nakagami, T., de Vries, R., Tateishi, T., Kondo, T., & Kaneko, S. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2003.02061.x · Cited by 67
Elens, L., Vandercam, B., Yombi, J. C., Lison, D., Wallemacq, P. E., & Haufroid, V. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.94 · Cited by 67
Wolf, S. J., Bachtiar, M., Wang, J., Sim, T. S., Chong, S. S., & Lee, C. G. L. (2011) · The Pharmacogenomics Journal · doi:10.1038/tpj.2011.16 · Cited by 66
Tsai, S., Lin, C.-Y., Wu, S., Hou, L. A., Ma, H., Tsai, L., & Hou, M. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.03.038 · Cited by 64
Kuzman, M. R., Medved, V., Božina, N., Hotujac, L., Šain, I., & Bilusic, H. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.06.006 · Cited by 62
Substrate-Dependent Effects of Human ABCB1 Coding Polymorphisms
Gow, J. M., Hodges, L. M., Chinn, L. W., & Kroetz, D. L. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.135194 · Cited by 62
Haerian, B. S., Lim, K. S., Tan, C. T., Raymond, A. A., & Mohamed, Z. (2011) · Pharmacogenomics · doi:10.2217/pgs.10.212 · Cited by 61
Gunes, A., Spina, E., Dahl, M., & Scordo, M. G. (2008) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3181858ca9 · Cited by 59
Jeong, H., Herskowitz, I., Kroetz, D. L., & Rine, J. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030039 · Cited by 58
Mattia, E. D., Toffoli, G., Polesel, J., D'Andrea, M. R., Corona, G., Zagonel, V., Buonadonna, A., Dreussi, E., & Cecchin, E. (2013) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328364b6cf · Cited by 57
How to Explain Multidrug Resistance in Epilepsy?
Löscher, W. (2005) · Epiliepsy currents/Epilepsy currents · doi:10.1111/j.1535-7511.2005.05311.x · Cited by 56
Kuzuya, T., Kobayashi, T., 森山, 奈., Nagasaka, T., Yokoyama, I., Uchida, K., Nakao, A., & Nabeshima, T. (2003) · Transplantation · doi:10.1097/01.tp.0000084873.20157.67 · Cited by 55
Lin, Y., Ellingrod, V. L., Bishop, J. R., & Miller, D. D. (2006) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000246761.82377.a6 · Cited by 54
ABCB1 G1199A Polymorphism and Ovarian Cancer Response to Paclitaxel
Gréen, H., Söderkvist, P., Rosenberg, P., Horváth, G., & Peterson, C. O. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21169 · Cited by 53
Kwan, P., Wong, V. C. N., Ng, P. W., Lui, C. H. T., Sin, N. C., Poon, W. S., Ng, H., Wong, K. S., & Baum, L. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.32 · Cited by 52
Provenzani, A., Notarbartolo, M., Labbozzetta, M., Poma, P., Biondi, F., Sanguedolce, R., Vizzini, G. B., Palazzo, U., Polidori, P., Triolo, F., et al. (2009) · PubMed · Cited by 51
Svirnovski, A. I., Шман, Т. В., Serhiyenka, T. F., Savitski, V. P., Smolnikova, V. V., & Fedasenka, U. U. (2009) · Hematology · doi:10.1179/102453309x426218 · Cited by 51
Mirza, N., Vasieva, O., Marson, A. G., & Pirmohamed, M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr365 · Cited by 51
Özbey, G., Yucel, B., Taycan, S. E., Kan, D., Bodur, N. E., Arslan, T., Perçin, E. F., Yüksel, N., Güzey, C., & Uluoğlu, C. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2013.09.004 · Cited by 51
Onizuka, M., Kunii, N., Toyosaki, M., Machida, S., Ohgiya, D., Ogawa, Y., Kawada, H., Inoko, H., & Ando, K. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.273 · Cited by 49
Seedhouse, C., Grundy, M. A., White, P., Li, Y., Fisher, J., Yakunina, D., Moorman, A. V., Hoy, T. G., Russell, N. H., Burnett, A. K., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1484 · Cited by 48
Crouthamel, M. H., Wu, D. Y., Yang, Z., & Ho, R. J. Y. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20743 · Cited by 46
Herrlinger, K. R., Koç, H., Winter, S., Teml, A., Stange, E., Fellermann, K., Fritz, P., Schwab, M. G., & Schaeffeler, E. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.348 · Cited by 46
Self-citationKarlsson, L., Gréen, H., Zackrisson, A. L., Bengtsson, F., Falk, I. J., Björn Carlsson, A., Ahlner, J., & Kugelberg, F. C. (2013) · International Journal of Legal Medicine · doi:10.1007/s00414-013-0849-0 · Cited by 44
Cho, J.-H., Yoon, Y.-D., Park, J.-Y., Song, E.-J., Choi, J., Yoon, S.-H., Park, S.-H., Kim, Y.-L., & Kim, C.-D. (2012) · Transplantation Proceedings · doi:10.1016/j.transproceed.2011.11.004 · Cited by 43
Data collection as a barrier to personalized medicine
Zakim, D., & Schwab, M. G. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.11.002 · Cited by 42
Self-citationLee, S. S., Kim, S., Kim, W., Thi-Le, H., Yoon, Y., Yea, S. S., & Shin, J. (2005) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000164293.75854.11 · Cited by 42
Mosyagin, I. G., Runge, U., Schroeder, H. W. S., Dazert, E., Vogelgesang, S., Siegmund, W., Warzok, R., & Cascorbi, I. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01661.x · Cited by 41
García-Cerrada, M., Macias, R. M., Cubero, J. J., Benítez, J., Caravaca, F., & Gervasini, G. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1355-x · Cited by 41
MDR1 gene polymorphisms and response to acute risperidone treatment
Kastelic, M., Koprivšek, J., Plesničar, B. K., Serretti, A., Mandelli, L., Locatelli, I., Grabnar, I., & Dolžan, V. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.01.005 · Cited by 39
Lin, D., Luo, R., Yu, T., Cai, X., Mao, M., & Yu, D. (2011) · Brain Research · doi:10.1016/j.brainres.2011.03.028 · Cited by 38
Ponnala, S., Chaudhari, J. R., Jaleel, M. A., Bhiladvala, D., Kaipa, P. R., Das, U. N., & Hasan, Q. A. (2012) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2011.0225 · Cited by 37
Elghannam, D. M., Ibrahim, L., Ebrahim, M., Azmy, E., & Hakeem, H. (2013) · Hematology · doi:10.1179/1607845413y.0000000102 · Cited by 37
Antidepressants and ABCB1 Gene C3435T Functional Polymorphism: A Naturalistic Study
Menu, P., Gressier, F., Verstuyft, C., Hardy, P., Becquemont, L., & Corruble, E. (2010) · Neuropsychobiology · doi:10.1159/000319361 · Cited by 36
Verschuren, J. J. W., Boden, H., Wessels, J. A. M., van der Hoeven, B. L., Trompet, S., Heijmans, B. T., Putter, H., Guchelaar, H., Schalij, M. J., & Jukema, J. W. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.07.020 · Cited by 36
Genetic Polymorphisms and Individualized Tacrolimus Dosing
Soria, M. A. L.-M., Berga, J. K., Catalán, S. B., Milara, J., Mateu, L. M. P., & Torres, N. (2010) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.08.001 · Cited by 35
Multidrug Resistance Protein: P‐Glycoprotein
Sharom, F. J. (2006) · Wiley eBooks · doi:10.1002/9780470140505.ch10 · Cited by 34
Beuselinck, B., Lambrechts, D., Brussel, T. V., Wolter, P., Cardinaels, N., Joniau, S., Lerut, E., Karadimou, A., Couchy, G., Sèbe, P., et al. (2014) · Acta Oncologica · doi:10.3109/0284186x.2014.918276 · Cited by 34
Cited by
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
Pharmacokinetic aspects of retinal drug delivery
del Amo, E. M., Rimpelä, A.-K., Heikkinen, E., Kari, O. K., Ramsay, E., Lajunen, T., Schmitt, M., Pelkonen, L., Bhattacharya, M., Richardson, D., et al. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.12.001 · Cited by 693
Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
Stillhart, C., Vučićević, K., Augustijns, P., Basit, A. W., Batchelor, H., Flanagan, T. R., Gesquiere, I., Greupink, R., Keszthelyi, D., Koskinen, M., et al. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105280 · Cited by 320
The blood–brain barrier in psychosis
Pollak, T. A., Drndarski, S., Stone, J. M., David, A. S., McGuire, P., & Abbott, N. J. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30293-6 · Cited by 307
Genovese, I., Ilari, A., Assaraf, Y. G., Fazi, F., & Colotti, G. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.10.003 · Cited by 156
Metadata
- Authors
- Wolking, S., Schaeffeler, E., Lerche, H., Schwab, M., & Nies, A. T.
- Venue
- Clinical Pharmacokinetics
- Published
- 2015-04-10
- Volume
- 54
- Issue
- 7
- Pages
- 709-735
- ISSN
- 0312-5963 (ISSN-L)
- 1179-1926
- OpenAlex
- W2066731188
- Cited by
- 309
- References
- 210
- FWCI
- 30.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.